Simone I Richardson1,2, Penny L Moore1,2,3. 1. Centre for HIV and STIs, National Institute for Communicable Diseases of the National Health Laboratory Service. 2. Faculty of Health Sciences, University of the Witwatersrand, Johannesburg. 3. Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Abstract
PURPOSE OF REVIEW: Although the goal of preventive HIV vaccine design is primarily the induction of broadly neutralizing antibodies (bNAbs), recent evidence suggests that a protective response will also benefit from Fc effector functions. Here, we provide an update on the antibody response to HIV infection, including both Fab and Fc-mediated antibody responses. We also highlight recent studies showing the interplay between these functions, focusing primarily on studies published in the last year. RECENT FINDINGS: Identification and characterization of bNAb donors continues to provide insights into viral factors that are potentially translatable to vaccine design. Improved and more diverse measures of Fc effector function, and modulators thereof, are enabling a deeper understanding of their role in infection. New data providing mechanistic links between the innate and adaptive humoral immune responses are creating exciting opportunities for vaccine strategies, with the aim of eliciting a polyfunctional protective response. SUMMARY: New insights into the overall humoral response to HIV infection are defining diverse and synergistic mechanisms required for antibody protection from HIV through vaccination.
PURPOSE OF REVIEW: Although the goal of preventive HIV vaccine design is primarily the induction of broadly neutralizing antibodies (bNAbs), recent evidence suggests that a protective response will also benefit from Fc effector functions. Here, we provide an update on the antibody response to HIV infection, including both Fab and Fc-mediated antibody responses. We also highlight recent studies showing the interplay between these functions, focusing primarily on studies published in the last year. RECENT FINDINGS: Identification and characterization of bNAb donors continues to provide insights into viral factors that are potentially translatable to vaccine design. Improved and more diverse measures of Fc effector function, and modulators thereof, are enabling a deeper understanding of their role in infection. New data providing mechanistic links between the innate and adaptive humoral immune responses are creating exciting opportunities for vaccine strategies, with the aim of eliciting a polyfunctional protective response. SUMMARY: New insights into the overall humoral response to HIV infection are defining diverse and synergistic mechanisms required for antibody protection from HIV through vaccination.
Authors: Amy W Chung; Jenniffer M Mabuka; Bongiwe Ndlovu; Anna Licht; Hannah Robinson; Yathisha Ramlakhan; Musie Ghebremichael; Tarylee Reddy; Philip J R Goulder; Bruce D Walker; Thumbi Ndung'u; Galit Alter Journal: AIDS Date: 2018-06-19 Impact factor: 4.177
Authors: Sai Priya Anand; Jérémie Prévost; Sophie Baril; Jonathan Richard; Halima Medjahed; Jean-Philippe Chapleau; William D Tolbert; Sharon Kirk; Amos B Smith; Bruce D Wines; Stephen J Kent; P Mark Hogarth; Matthew S Parsons; Marzena Pazgier; Andrés Finzi Journal: J Virol Date: 2019-01-17 Impact factor: 5.103
Authors: Cassandra A Simonich; Katherine L Williams; Hans P Verkerke; James A Williams; Ruth Nduati; Kelly K Lee; Julie Overbaugh Journal: Cell Date: 2016-06-23 Impact factor: 41.582
Authors: María Julia Ruiz; Jimena Salido; Lorena Abusamra; Yanina Ghiglione; Cintia Cevallos; Gabriel Damilano; Ana María Rodriguez; César Trifone; Natalia Laufer; Luis D Giavedoni; Omar Sued; Horacio Salomón; María Magdalena Gherardi; Gabriela Turk Journal: EBioMedicine Date: 2017-11-03 Impact factor: 8.143
Authors: Claus Kadelka; Thomas Liechti; Hanna Ebner; Merle Schanz; Peter Rusert; Nikolas Friedrich; Emanuel Stiegeler; Dominique L Braun; Michael Huber; Alexandra U Scherrer; Jacqueline Weber; Therese Uhr; Herbert Kuster; Benjamin Misselwitz; Matthias Cavassini; Enos Bernasconi; Matthias Hoffmann; Alexandra Calmy; Manuel Battegay; Andri Rauch; Sabine Yerly; Vincent Aubert; Thomas Klimkait; Jürg Böni; Roger D Kouyos; Huldrych F Günthard; Alexandra Trkola Journal: J Exp Med Date: 2018-05-24 Impact factor: 14.307
Authors: Kevin Wiehe; Todd Bradley; R Ryan Meyerhoff; Connor Hart; Wilton B Williams; David Easterhoff; William J Faison; Thomas B Kepler; Kevin O Saunders; S Munir Alam; Mattia Bonsignori; Barton F Haynes Journal: Cell Host Microbe Date: 2018-05-31 Impact factor: 31.316
Authors: Julia Roider; Takashi Maehara; Abigail Ngoepe; Duran Ramsuran; Maximilian Muenchhoff; Emily Adland; Toby Aicher; Samuel W Kazer; Pieter Jooste; Farina Karim; Warren Kuhn; Alex K Shalek; Thumbi Ndung'u; Lynn Morris; Penny L Moore; Shiv Pillai; Henrik Kløverpris; Philip Goulder; Alasdair Leslie Journal: Front Immunol Date: 2018-09-12 Impact factor: 7.561
Authors: Ian Setliff; Wyatt J McDonnell; Nagarajan Raju; Robin G Bombardi; Amyn A Murji; Cathrine Scheepers; Rutendo Ziki; Charissa Mynhardt; Bryan E Shepherd; Alusha A Mamchak; Nigel Garrett; Salim Abdool Karim; Simon A Mallal; James E Crowe; Lynn Morris; Ivelin S Georgiev Journal: Cell Host Microbe Date: 2018-05-31 Impact factor: 21.023
Authors: Bailey B Banach; Prabhanshu Tripathi; Lais Da Silva Pereira; Jason Gorman; Thuy Duong Nguyen; Marlon Dillon; Ahmed S Fahad; Patience K Kiyuka; Bharat Madan; Jacy R Wolfe; Brian Bonilla; Barbara Flynn; Joseph R Francica; Nicholas K Hurlburt; Neville K Kisalu; Tracy Liu; Li Ou; Reda Rawi; Arne Schön; Chen-Hsiang Shen; I-Ting Teng; Baoshan Zhang; Marie Pancera; Azza H Idris; Robert A Seder; Peter D Kwong; Brandon J DeKosky Journal: J Exp Med Date: 2022-06-23 Impact factor: 17.579
Authors: Simone I Richardson; Bronwen E Lambson; Andrew R Crowley; Arman Bashirova; Cathrine Scheepers; Nigel Garrett; Salim Abdool Karim; Nonhlanhla N Mkhize; Mary Carrington; Margaret E Ackerman; Penny L Moore; Lynn Morris Journal: PLoS Pathog Date: 2019-12-16 Impact factor: 6.823